P&G Appoints Ashley McEvoy to Board of Directors

Procter & Gamble has announced the addition of Ashley McEvoy to its board of directors. McEvoy, who previously served as executive vice president and global president of MedTech at Johnson & Johnson, will assume her new role effective December 12, 2023.

With nearly three decades of experience at Johnson & Johnson, McEvoy excelled in leading the Medical Devices segment, a business valued at $27 billion, the second largest worldwide. In his career, he drove the company’s foray into telehealth, robotics and digital surgery, in addition to leading more than $20 billion in mergers and acquisitions. Previously, he held key roles, including presidency of areas such as Consumer Medical Devices, Vision Care and Ethicon Products, accumulating extensive management and marketing experience.

Jon Moeller, Chairman of the Board, President and Chief Executive Officer of P&G said. “Ashley’s transformative leadership, track record of innovation and breadth of experience in serving consumers and growing markets will be an asset to P&G. Her expertise will further strengthen the capability of our Board as we improve the lives of consumers around the world“.